Concepedia

Da Xu

DX

Statistics

Publications

2

Citations

40

H-Index

2

Active since

2022

Affiliations

Third Affiliated Hospital of Harbin Medical University(Current)

Peking University Cancer Hospital

Peking University

Harbin Medical University

Da Xu is an author at Third Affiliated Hospital of Harbin Medical University specializing in cancer therapeutics, medicine, and oncology.

Top concepts

Publications per year

2022–2025

2

Publications

2

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial

Da Xu, Hongwei Wang, Kemin Jin et al. · Nature Communications · 2025 · 25 citations · Full text

, , +20

A phase II study combining KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) and lenvatinib in the treatment for advanced unresectable or metastatic hepatocellular carcinoma (HCC): Updated efficacy and safety results.

Baocai Xing, Da Xu, Yanqiao Zhang et al. · Journal of Clinical Oncology · 2022 · 15 citations

, , +17

1–2 of 2